Please assess the completion status of the following clinical trial:

Trial Title: Bupropion Alone or Combined With Nicotine Gum

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Smoke 10 or more cigarettes per day~* Motivated to quit~* No physical or mental health issues that would prevent participation~* Not pregnant or willing to prevent pregnancy during treatment~Exclusion Criteria:~* Carbon monoxide (CO) breath test score below 10 parts per million (ppm)~* Center for Epidemiologic Studies Depression Scale (CES-D) score greater than 16~* Heavy alcohol use~* History of eating disorder~* Suicidality

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Active bupropion-Active gum (Type: ACTIVE_COMPARATOR): 150 mg bupropion twice daily + 4 mg nicotine gum as needed (up to 12 pcs/day)
- Active bupropion-Placebo gum (Type: ACTIVE_COMPARATOR): 150mg bupropion twice daily + placebo gum as needed (up to 12 pcs/day)
- Placebo medication-Placebo gum (Type: ACTIVE_COMPARATOR): Placebo bupropion, twice daily, plus placebo gum as needed (up to 12 pcs/day)

Based on this trial design, predict the completion outcome and termination type (if applicable).